Wealth Enhancement Advisory Services’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
SCM
S
Wealth Enhancement Advisory Services's NVAX Position: Q2 2026 in Review
Wealth Enhancement Advisory Services opened a new position in Novavax (NVAX) in Q2 2026: 31,387 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #3230 among its holdings. This is a return to the name: Wealth Enhancement Advisory Services previously reported a position in NVAX as recently as Q2 2025.
Wealth Enhancement Advisory Services first reported a position in NVAX in Q3 2024 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Wealth Enhancement Advisory Services held 31,387 shares of Novavax worth $293K as of Q2 2026.
- Novavax was a new Wealth Enhancement Advisory Services position in Q2 2026.
- Novavax made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3230 holding.
- Wealth Enhancement Advisory Services first reported a position in Novavax in Q3 2024 and has held it in 4 quarters since.
- 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.